These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 22128893

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Development of behaviour change communication strategy for a vaccination-linked malaria control tool in southern Tanzania.
    Mushi AK, Schellenberg J, Mrisho M, Manzi F, Mbuya C, Mponda H, Mshinda H, Tanner M, Alonso P, Pool R, Schellenberg D.
    Malar J; 2008 Sep 29; 7():191. PubMed ID: 18823531
    [Abstract] [Full Text] [Related]

  • 4. The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania.
    Pool R, Mushi A, Schellenberg JA, Mrisho M, Alonso P, Montgomery C, Tanner M, Mshinda H, Schellenberg D.
    Malar J; 2008 Oct 21; 7():213. PubMed ID: 18939971
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial.
    Dicko A, Toure SO, Traore M, Sagara I, Toure OB, Sissoko MS, Diallo AT, Rogier C, Salomon R, de Sousa A, Doumbo OK.
    BMC Public Health; 2011 Jul 18; 11():573. PubMed ID: 21767403
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal.
    Ndiaye M, Tine R, Faye B, Ndiaye JL, Diouf I, Lo AC, Sylla K, Dieng Y, Hallett R, Alifrangis M, Gaye O.
    C R Biol; 2013 Jul 18; 336(5-6):295-300. PubMed ID: 23916206
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy.
    Nsimba SE.
    J Ethnobiol Ethnomed; 2006 Jan 10; 2():5. PubMed ID: 16403225
    [Abstract] [Full Text] [Related]

  • 13. Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi.
    Msyamboza KP, Savage EJ, Kazembe PN, Gies S, Kalanda G, D'Alessandro U, Brabin BJ.
    Trop Med Int Health; 2009 Feb 10; 14(2):183-9. PubMed ID: 19207178
    [Abstract] [Full Text] [Related]

  • 14. A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.
    Gies S, Coulibaly SO, Ouattara FT, Ky C, Brabin BJ, D'Alessandro U.
    Malar J; 2008 Sep 18; 7():180. PubMed ID: 18801158
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants.
    Mayor A, Serra-Casas E, Sanz S, Aponte JJ, Macete E, Mandomando I, Puyol L, Berzosa P, Dobaño C, Aide P, Sacarlal J, Benito A, Alonso P, Menéndez C.
    J Infect Dis; 2008 Jun 15; 197(12):1737-42. PubMed ID: 18419347
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. From strategy development to routine implementation: the cost of Intermittent Preventive Treatment in Infants for malaria control.
    Manzi F, Hutton G, Schellenberg J, Tanner M, Alonso P, Mshinda H, Schellenberg D.
    BMC Health Serv Res; 2008 Jul 31; 8():165. PubMed ID: 18671874
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants.
    Kobbe R, Kreuzberg C, Adjei S, Thompson B, Langefeld I, Thompson PA, Abruquah HH, Kreuels B, Ayim M, Busch W, Marks F, Amoah K, Opoku E, Meyer CG, Adjei O, May J.
    Clin Infect Dis; 2007 Jul 01; 45(1):16-25. PubMed ID: 17554695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.